SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-023969
Filing Date
2022-05-04
Accepted
2022-05-04 16:11:53
Documents
14
Period of Report
2022-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea159377-8k_optimizerx.htm   iXBRL 8-K 27374
2 PRESS RELEASE, DATED MAY 4, 2022 ea159377ex99-1_optimizerx.htm EX-99.1 98787
3 GRAPHIC ex99-1_001.jpg GRAPHIC 14645
  Complete submission text file 0001213900-22-023969.txt   333896

Data Files

Seq Description Document Type Size
4 XBRL LABEL FILE oprx-20220504_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE oprx-20220504_pre.xml EX-101.PRE 22599
6 XBRL SCHEMA FILE oprx-20220504.xsd EX-101.SCH 3039
8 EXTRACTED XBRL INSTANCE DOCUMENT ea159377-8k_optimizerx_htm.xml XML 3597
Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 22891620
SIC: 7389 Services-Business Services, NEC